Bulletin
Investor Alert

23andMe Holding Co.

NAS: ME

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 22, 2021, 7:59 p.m.

ME
/zigman2/quotes/222659849/composite

$

10.82

Change

-0.05 -0.46%

Volume

Volume 41,330

Quotes are delayed by 20 min

/zigman2/quotes/222659849/composite

Previous close

$ 10.33

$ 10.87

Change

+0.54 +5.23%

Day low

Day high

$9.28

$10.99

Open

52 week low

52 week high

$7.01

$18.16

Open

Company Description

23andMe Holding Co. is consumer genetics and research company, which engages to help people access, understand, and benefit from the human genome. It provides direct access to genetic information with multiple Food and Drug Administration authorizations for genetic health risk reports. The firm’s re...

23andMe Holding Co. is consumer genetics and research company, which engages to help people access, understand, and benefit from the human genome. It provides direct access to genetic information with multiple Food and Drug Administration authorizations for genetic health risk reports. The firm’s research platform has generated publications on the genetic underpinnings of a range of diseases, conditions, and traits. The platform also powers the 23andMe therapeutics group, pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory, and cardiovascular diseases, in addition to other therapeutic areas. The company was founded by Anne E. Wojcickiin 2006 and is headquartered in Sunnyvale, CA.

Valuation

Price to Book Ratio

1.72

Efficiency

Liquidity

Current Ratio

0.07

Quick Ratio

0.07

Cash Ratio

0.04

Profitability

Capital Structure

Officers and Executives

Name Age Officer Since Title
Ms. Anne E. Wojcicki 46 2006 Chief Executive Officer & Director
Mr. Steven Schoch - 2018 Chief Financial & Accounting Officer
Mr. Steve Lemon 57 2010 Vice President-Engineering
Dr. Joyce Tung 42 2007 Vice President-Research
Dr. L. Okey Onyejekwe 45 - VP-Consumer Clinical Operations & Medical Affairs

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/14/2021 Peter J. Taylor
Director
18,421   Award at $0 per share. 0
09/14/2021 Peter J. Taylor
Director
36,842   Award at $0 per share. 0
09/14/2021 Valerie Montgomery Rice
Director
18,421   Award at $0 per share. 0
09/14/2021 Valerie Montgomery Rice
Director
36,842   Award at $0 per share. 0
09/14/2021 Roelof Frederik Botha
Director
18,421   Award at $0 per share. 0
09/14/2021 Richard H. Scheller
Director
18,421   Award at $0 per share. 0
09/14/2021 Patrick Shuao-Fong Chung
Director
18,421   Award at $0 per share. 0
09/14/2021 Evan M. Lovell
Director
18,421   Award at $0 per share. 0
09/14/2021 Neil Mohan
Director
18,421   Award at $0 per share. 0
/news/latest/company/us/me

MarketWatch News on ME

  1. 23andMe buys telemedicine specialist Lemonaid Health

    7:20 a.m. Oct. 22, 2021

    - Steve Gelsi

  2. Dow Sees Worst Week In 8 Months. Inflation Trade Sputters.

    4:56 p.m. June 18, 2021

    - Barron's Online

  3. These 3 Firms Could Be the Next SPAC Targets

    3:39 p.m. Feb. 5, 2021

    - Barron's Online

  4. 23andMe to go public via merger with Richard Branson's SPAC VG Acquisition

    8:36 a.m. Feb. 4, 2021

    - Ciara Linnane

  5. 23andMe deal has enterprise value of about $3.5 bln

    8:37 a.m. Feb. 4, 2021

    - Ciara Linnane

  6. The Space SPAC Stable Road Spiked 34%. The Question Is Why.

    5:15 p.m. Jan. 19, 2021

    - Barron's Online

/news/nonmarketwatch/company/us/me

Other News on ME

  1. Why 23andMe Stock Dropped Today

    11:42 a.m. Oct. 22, 2021

    - Motley Fool

  2. Why 23andMe Stock Has Jumped 16% So Far This Week

    10:08 p.m. Oct. 21, 2021

    - Motley Fool

  3. ME, CYCN and FWBI among pre market gainers

    8:28 a.m. Oct. 20, 2021

    - Seeking Alpha

  4. 23andMe Stock Could Be a Big Winner If This 1 Thing Happens

    7:45 a.m. Oct. 17, 2021

    - Motley Fool

  5. FUTU, WTRH and BWEN among midday movers

    1:45 p.m. Oct. 15, 2021

    - Seeking Alpha

  6. Why 23andMe Stock Jumped 16% Today

    1:40 p.m. Oct. 15, 2021

    - Motley Fool

  7. 3 Top Stocks You Can Still Buy for Under $20 a Share

    11:00 a.m. Oct. 15, 2021

    - Motley Fool

  8. RIOT, BTBT and HUT among pre market gainers

    8:26 a.m. Oct. 15, 2021

    - Seeking Alpha

  9. 3 Stocks That Can Turn $10,000 Into $50,000 by 2025

    6:17 a.m. Oct. 9, 2021

    - Motley Fool

  10. Regulatory Hurdles Block a Cancer Miracle

    1:35 p.m. Oct. 8, 2021

    - Allysia Finley

  11. Education-Technology Startup Multiverse Raises $130 Million

    7:00 a.m. Sept. 28, 2021

    - Maria Armental

  12. Here's Why I Bought This Recent Genetics IPO

    6:17 a.m. Sept. 22, 2021

    - Motley Fool

  13. 3 Stocks I Bought That Could Produce 10X Returns

    6:22 a.m. Sept. 15, 2021

    - Motley Fool

  14. 23andMe maintains FY22 outlook

    7:55 a.m. Sept. 10, 2021

    - Seeking Alpha

  15. Loading more headlines...

At a Glance

23andMe Holding Co.

223 North Mathilda Avenue

Sunnyvale, California 94086

Phone

1 6509386300

Industry

-

Sector

-

Fiscal Year-end

12/2021

Revenue

N/A

Net Income

$-48.60M

Employees

-

/news/pressrelease/company/us/me

Press Releases on ME

  1. 23andMe Agrees to Acquire Lemonaid Health

    6:55 a.m. Oct. 22, 2021

    - GlobeNewswire

  2. 23andMe to Present at the Wells Fargo Healthcare Conference

    4:05 p.m. Sept. 1, 2021

    - GlobeNewswire

  3. 23andMe Reports FY2022 First Quarter Financial Results

    7:00 a.m. Aug. 13, 2021

    - GlobeNewswire

  4. 23andMe to Report FY2022 First Quarter Financial Results

    7:15 a.m. July 29, 2021

    - GlobeNewswire

  5. Industry Leaders Join 23andMe Board of Directors

    8:00 a.m. June 21, 2021

    - GlobeNewswire

  6. New 23andMe to Trade on Nasdaq as "ME"

    4:55 p.m. May 26, 2021

    - PR Newswire - PRF

  7. SHAREHOLDER ALERT: WeissLaw LLP Investigates VG Acquisition Corp.

    5:13 p.m. Feb. 4, 2021

    - PR Newswire - PRF

Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.